Speaker illustration

Doctor Eui-Soon Kim

Korea Advanced Institute of Science and Technology, Daejeon (Korea (Republic of))

Member of:

European Society of Cardiology

Real-world eligibility and cost-effectiveness analysis for empagliflozin in patients with heart failure

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure - Pharmacotherapy

Thumbnail

This platform is supported by

logo Novo Nordisk